Anti-STX3/ STX3A monoclonal antibody

Anti-STX3/ STX3A antibody for FACS & in-vivo assay

Target products collectionGo to STX3/STX3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1727-Ab-1/ GM-Tg-hg-MP1727-Ab-2Anti-Human STX3 monoclonal antibodyHuman
GM-Tg-rg-MP1727-Ab-1/ GM-Tg-rg-MP1727-Ab-2Anti-Rat STX3 monoclonal antibodyRat
GM-Tg-mg-MP1727-Ab-1/ GM-Tg-mg-MP1727-Ab-2Anti-Mouse STX3 monoclonal antibodyMouse
GM-Tg-cynog-MP1727-Ab-1/ GM-Tg-cynog-MP1727-Ab-2Anti-Cynomolgus/ Rhesus macaque STX3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1727-Ab-1/ GM-Tg-felg-MP1727-Ab-2Anti-Feline STX3 monoclonal antibodyFeline
GM-Tg-cang-MP1727-Ab-1/ GM-Tg-cang-MP1727-Ab-2Anti-Canine STX3 monoclonal antibodyCanine
GM-Tg-bovg-MP1727-Ab-1/ GM-Tg-bovg-MP1727-Ab-2Anti-Bovine STX3 monoclonal antibodyBovine
GM-Tg-equg-MP1727-Ab-1/ GM-Tg-equg-MP1727-Ab-2Anti-Equine STX3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1727-Ab-1/ GM-Tg-hg-MP1727-Ab-2; GM-Tg-rg-MP1727-Ab-1/ GM-Tg-rg-MP1727-Ab-2;
GM-Tg-mg-MP1727-Ab-1/ GM-Tg-mg-MP1727-Ab-2; GM-Tg-cynog-MP1727-Ab-1/ GM-Tg-cynog-MP1727-Ab-2;
GM-Tg-felg-MP1727-Ab-1/ GM-Tg-felg-MP1727-Ab-2; GM-Tg-cang-MP1727-Ab-1/ GM-Tg-cang-MP1727-Ab-2;
GM-Tg-bovg-MP1727-Ab-1/ GM-Tg-bovg-MP1727-Ab-2; GM-Tg-equg-MP1727-Ab-1/ GM-Tg-equg-MP1727-Ab-2
Products NameAnti-STX3 monoclonal antibody
Formatmab
Target NameSTX3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-STX3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species STX3/ STX3A VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP000571human STX3 Lentivirus plasmid
    ORF Viral VectorvGMLP000571human STX3 Lentivirus particle
    ORF Viral VectorpGMLPm000452mouse Stx3 Lentivirus plasmid
    ORF Viral VectorvGMLPm000452mouse Stx3 Lentivirus particle


    Target information

    Target IDGM-MP1727
    Target NameSTX3
    Gene ID6809,20908,81802,698953,100855648,101099148,513275,100060878
    Gene Symbol and SynonymsDIAR12,MVID2,RDMVID,STX3,STX3A,Syn-3
    Uniprot AccessionQ13277,Q08849
    Uniprot Entry NameSTX3_HUMAN,STX3_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166900
    Target ClassificationN/A

    The target: STX3, gene name: STX3, also named as STX3A. The gene is a member of the syntaxin family. The encoded protein is targeted to the apical membrane of epithelial cells where it forms clusters and is important in establishing and maintaining polarity necessary for protein trafficking involving vesicle fusion and exocytosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.